Elzbieta Zlowocka-Perlowska | Micronutrients and Kidney Cancer | Best Researcher Award

Dr. Elzbieta Zlowocka-Perlowska | Micronutrients and Kidney Cancer | Best Researcher Award

Pomeranian Medical University | Poland

Dr. Elżbieta Złowocka-Perłowska is an accomplished Polish medical scientist specializing in molecular oncology and hereditary cancer research. She earned her master’s degree in biology from the University of Szczecin and a doctorate in medical sciences with highest distinction from the Pomeranian Medical University in Szczecin, where she currently serves at the Center for Hereditary Tumors and the Department of Genetics and Pathomorphology. Her professional expertise lies in molecular diagnostics, cancer biomarkers, and the prognostic role of trace and microelements in bladder and kidney cancers. She leads innovative research investigating correlations between blood and serum element levels and patient survival, aiming to integrate these biomarkers into predictive cancer models for personalized therapy development. Dr. Złowocka-Perłowska possesses strong research skills in molecular genetics, laboratory diagnostics, epidemiological modeling, and translational oncology. Her distinguished career includes numerous national and international awards, such as recognition from the World Scientist Forum and multiple Rector’s Awards, along with significant contributions to over fifty scientific publications and several patents. She has also collaborated internationally and mentored emerging researchers. Through her pioneering work, Dr. Złowocka-Perłowska continues to advance the understanding of hereditary and molecular mechanisms in cancer, contributing to future innovations in clinical diagnostics and targeted therapies.

Profile: ORCID

Featured Publications

Hanping Shi | Nutrition| Best Researcher Award

Dr. Hanping Shi | Nutrition| Best Researcher Award

Dr. Han Ping Shi, M.D., Ph.D., FACS, is an internationally recognized surgeon-scientist in gastrointestinal surgery and clinical nutrition 👨‍🔬. Born in Hubei, China 🇨🇳 (1961), he currently serves as Professor of Surgery and Surgeon-in-Chief at Beijing Shijitan Hospital, Capital Medical University 🏥. With over 30 years of clinical, research, and academic leadership, Dr. Shi has contributed extensively to surgical innovation and translational medicine 🧬. He has trained numerous graduate students 🎓 and held visiting scholar and postdoctoral roles in top U.S. institutions including Johns Hopkins and Rutgers 🏛️. As editor-in-chief and reviewer for major journals 📚, he actively shapes scientific discourse. He is a member of many national and international surgical societies 🌐 and has significantly advanced cancer metabolism, trauma care, and nutritional surgery 🍽️. Respected globally, Dr. Shi combines surgical excellence with academic distinction 🏅.

Profile

Education 🎓

🩺 M.D. – Wuhan University School of Medicine, Wuhan, China (1984)
📚 M.Med.S. – Second Military Medical University, Shanghai, China (1990)
🎓 Ph.D. – Second Military Medical University, Shanghai, China (1993)
📖 His educational foundation spans clinical medicine, military medical training, and advanced surgical research, establishing a base for international medical collaborations. He engaged in advanced studies at the National Defense University of Science and Technology 🎖️ and further developed his surgical acumen through postdoctoral training in the U.S., including Sinai Hospital/Johns Hopkins and New Jersey Medical School 🌎. His education reflects rigorous academic pursuit and hands-on surgical expertise 🧠.

Experience 👨‍🏫

Dr. Shi has served in various leadership roles across premier hospitals in China 🇨🇳. Since 2017, he has been Chairman & Surgeon-in-Chief at Beijing Shijitan Hospital 🏥. Previously, he held similar positions at Sun Yat-sen University and the Chinese Academy of Sciences 🔬. His U.S. experience includes fellowships and instructor roles at Johns Hopkins and Rutgers University from 1999–2002 🇺🇸. He has trained surgeons, managed departments, and advanced surgical nutrition and GI oncology 🦠. His editorial and academic leadership spans major journals and medical organizations 📘. From clinical to administrative excellence, Dr. Shi’s impact spans continents, nurturing a new generation of surgical leaders 💼.

Awards & Recognitions 🏅

🌟 Fellow of the American College of Surgeons (FACS)
🎖️ Editor-in-Chief of top journals including Electronic Journal of Metabolism and Nutrition of Cancer
🏅 Reviewer for the Chinese Medical Science and Technology Award, National Natural Science Foundation of China, and others
🎓 Advisor to 16+ postgraduate students
📘 Honored roles as Associate Editor for Clinical Nutrition, ESPEN, Journal of Cachexia, Sarcopenia and Muscle
🌐 Active member of elite surgical societies (ISS/SIC, IATSIC, IASMEN)
🥇 Former Vice Board Chairman, Chinese Clinical Medical Association
🛡️ Standing committee roles in trauma, cancer, and nutrition societies
His career is decorated with academic accolades, leadership honors, and international recognition in the surgical community 💫.

Research Interests 🔬

Dr. Shi’s research focuses on gastrointestinal surgery, surgical metabolism, cancer nutrition, trauma surgery, and translational medicine 🔍. His pioneering work on parenteral and enteral nutrition supports surgical recovery and cancer care 🍲. With deep interest in cachexia, wound healing, and inflammation, he integrates molecular biology with clinical outcomes 🧬. He promotes precision nutrition and individualized surgical support in oncology and critical care 💡. As an editorial board leader, he advances research in metabolism and surgical outcomes 📊. His U.S. postdoctoral work further refined his molecular approach to surgery and metabolism 🔬. Dr. Shi bridges East-West medical research through academic publications and society memberships 🌏.

Publications 
  • Effects of Glucomannan Supplementation on Type II Diabetes Mellitus in Humans: A Meta-Analysis

    Nutrients
    2023-01 | Journal article | Author
    CONTRIBUTORS: Zhanzhi Zhang; Yu Zhang; Xiaomei Tao; Yuying Wang; Benqiang Rao; Hanping Shi
  • Mid-Arm Muscle Circumference or Body Weight-Standardized Hand Grip Strength in the GLIM Superiorly Predicts Survival in Chinese Colorectal Cancer Patients

    Nutrients
    2022-12 | Journal article | Author
    CONTRIBUTORS: Tiantian Wu; Hongxia Xu; Yuanlin Zou; Jiuwei Cui; Kedi Xu; Mingming Zhou; Pengxia Guo; Haoqing Cheng; Hanping Shi; Chunhua Song et al.
  • The Association of Serum L-Carnitine Concentrations with the Risk of Cancer in Chinese Adults with Hypertension

    Nutrients
    2022-11 | Journal article | Author
    CONTRIBUTORS: Tong Liu; Chenan Liu; Xiaomeng Wang; Yaping Wei; Shuqun Li; Yun Song; Ping Chen; Lishun Liu; Binyan Wang; Hanping Shi
  • C‐Reactive Protein Trajectories and the Risk of All Cancer Types: A Prospective Cohort Study

    International Journal of Cancer
    2022-04-03 | Journal article
    Part of ISSN: 0020-7136
    Part of ISSN: 1097-0215